Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Consolidated Net Income: 2020-2024

Historic Consolidated Net Income for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to -$130.3 million.

  • Tango Therapeutics' Consolidated Net Income rose 154.46% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 18.57%. This contributed to the annual value of -$130.3 million for FY2024, which is 28.07% down from last year.
  • Tango Therapeutics' Consolidated Net Income amounted to -$130.3 million in FY2024, which was down 28.07% from -$101.7 million recorded in FY2023.
  • In the past 5 years, Tango Therapeutics' Consolidated Net Income ranged from a high of -$52.0 million in FY2020 and a low of -$130.3 million during FY2024.
  • In the last 3 years, Tango Therapeutics' Consolidated Net Income had a median value of -$108.2 million in 2022 and averaged -$113.4 million.
  • Per our database at Business Quant, Tango Therapeutics' Consolidated Net Income tumbled by 85.81% in 2022 and then increased by 5.99% in 2023.
  • Over the past 5 years, Tango Therapeutics' Consolidated Net Income (Yearly) stood at -$52.0 million in 2020, then decreased by 12.07% to -$58.2 million in 2021, then plummeted by 85.81% to -$108.2 million in 2022, then climbed by 5.99% to -$101.7 million in 2023, then dropped by 28.07% to -$130.3 million in 2024.